(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 1.44% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Inspire Medical Systems's revenue in 2026 is $915,247,000.On average, 19 Wall Street analysts forecast INSP's revenue for 2026 to be $24,785,074,211, with the lowest INSP revenue forecast at $23,323,671,090, and the highest INSP revenue forecast at $25,788,348,198. On average, 19 Wall Street analysts forecast INSP's revenue for 2027 to be $25,756,365,598, with the lowest INSP revenue forecast at $23,521,329,320, and the highest INSP revenue forecast at $27,833,505,798.
In 2028, INSP is forecast to generate $27,739,574,919 in revenue, with the lowest revenue forecast at $25,159,068,937 and the highest revenue forecast at $30,570,755,333.